Amgen aktiekurs
AMGN
#78

2.377,29 kr.
  

1.18%

Amgen Info

Markedsværdi
1,28T kr.

1.18%

Daglig Volumen
0 kr.
Hjemmeside
Aktivtype
Stock
Medarbejdere
28000
Grundlagt
Apr 8, 1980
Primær børs
Nasdaq
Branche
Biological Products, (No Diagnostic Substances)
CIK-nummer
0000318154

Tokeniserede aktiedata

Gennemsnitlig tokeniseret pris
2,4K kr.
Prisforskel
+25,43 kr.(+1.07%)
Tokeniseret markedsværdi
21,59K kr.

0.68%

Tokeniseret volumen (24 timer)
5,45M kr.

4.86%

Udstedere
Kontrakter
Explorers
AMGN til USD-konvertering
AMGN
DKK
Prispræstation
Lav
2,35K kr.
Høj
2,4K kr.

Indlæser data

Vent venligst, vi indlæser diagramdata

Amgen community

skeleton-white
 
 
 
 
 
 

About Amgen

What is Amgen?

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen Live Prisdata

The current price of Amgen in the market is 2.377,29 kr., with a 24-hour trading volume of 0 kr.. The asset's market cap is 1,28T kr., after moving -1.19% in the last day.

Tokenized Amgen is trading at 2.402,73 kr., with a tokenized market cap of 21,59K kr. and a 24-hour trading volume of 5,45M kr.. The tokenized asset has moved -0.68% in the past 24 hours.